These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30170274)

  • 1. Investigating cancer patient acceptance of Whole Body MRI.
    Oliveri S; Pricolo P; Pizzoli S; Faccio F; Lampis V; Summers P; Petralia G; Pravettoni G
    Clin Imaging; 2018; 52():246-251. PubMed ID: 30170274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary observations regarding the expectations, acceptability and satisfaction of whole-body MRI in self-referring asymptomatic subjects.
    Busacchio D; Mazzocco K; Gandini S; Pricolo P; Masiero M; Summers PE; Pravettoni G; Petralia G
    Br J Radiol; 2021 Feb; 94(1118):20191031. PubMed ID: 33237810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations.
    Evans RE; Taylor SA; Beare S; Halligan S; Morton A; Oliver A; Rockall A; Miles A
    Br J Radiol; 2018 Jun; 91(1086):20170731. PubMed ID: 29528257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
    Miles A; Evans RE; Halligan S; Beare S; Bridgewater J; Goh V; Janes SM; Navani N; Oliver A; Morton A; Morris S; Rockall A; Taylor SA;
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):537-545. PubMed ID: 32410378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient centered radiology: investigating 3 Tesla whole body MRI acceptance in cancer patients.
    Rossi A; Prochowski Iamurri A; Diano D; Oboldi D; Sintuzzi E; Maurizio L; Andalò A; Cavallucci M; Ferroni F; Amadori E; Barone D; Petralia G
    Radiol Med; 2023 Aug; 128(8):960-969. PubMed ID: 37395842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
    Dyrberg E; Larsen EL; Hendel HW; Thomsen HS
    Acta Radiol; 2018 Sep; 59(9):1119-1125. PubMed ID: 29313360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
    Taylor SA; Mallett S; Miles A; Beare S; Bhatnagar G; Bridgewater J; Glynne-Jones R; Goh V; Groves AM; Janes SM; Koh DM; Morris S; Morton A; Navani N; Oliver A; Padhani AR; Punwani S; Rockall AG; Halligan S
    BMC Cancer; 2017 May; 17(1):299. PubMed ID: 28464835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of whole-body MRI for cancer screening in children and young people with ataxia telangiectasia: A mixed methods cross-sectional study.
    Neves R; Panek R; Clarkson K; Panagioti O; Fernandez NS; Wilne S; Suri M; Whitehouse WP; Jagani S; Dandapani M; Glazebrook C; Dineen RA
    Cancer Med; 2024 Jul; 13(14):e70049. PubMed ID: 39056567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological characteristics and satisfaction for the whole-body MRI in cancer screening.
    Busacchio D; Mazzoni D; Mazzocco K; Pricolo P; Summers PE; Petralia G; Pravettoni G
    Psychol Health Med; 2023 Feb; 28(2):548-554. PubMed ID: 36148490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
    Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional survey.
    Pinto P; Valentin L; Borčinová M; Wiesnerová M; Filip F; Burgetova A; Masek M; Lambert L; Chiappa V; Franchi D; Testa AC; Moro F; Avesani G; Panico C; Alessi S; Pricolo P; Vigorito R; Calareso G; Kocian R; Slama J; Fagotti A; Urbinati AMV; Signorelli M; Bertolina F; Cibula D; Fischerova D
    Int J Gynecol Cancer; 2024 Jun; 34(6):871-878. PubMed ID: 38531539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.
    Zugni F; Padhani AR; Koh DM; Summers PE; Bellomi M; Petralia G
    Cancer Imaging; 2020 May; 20(1):34. PubMed ID: 32393345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
    Evans REC; Taylor SA; Kalasthry J; Sakai NS; Miles A;
    Clin Radiol; 2020 Apr; 75(4):308-315. PubMed ID: 31836179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
    Herrmann K; Queiroz M; Huellner MW; de Galiza Barbosa F; Buck A; Schaefer N; Stolzman P; Veit-Haibach P
    BMC Cancer; 2015 Dec; 15():1002. PubMed ID: 26699124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
    Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR
    Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body MRI for the staging and follow-up of patients with metastasis.
    Schmidt GP; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update.
    Friedman DN; Hsu M; Moskowitz CS; Francis JH; Lis E; Fleischut MH; Oeffinger KC; Walsh M; Tonorezos ES; Sklar CA; Abramson DH; Dunkel IJ
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28389. PubMed ID: 32386119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.
    Evans R; Taylor S; Janes S; Halligan S; Morton A; Navani N; Oliver A; Rockall A; Teague J; Miles A;
    BMJ Open; 2017 Sep; 7(9):e016391. PubMed ID: 28882915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
    Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
    Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review.
    Smets AM; Deurloo EE; Slager TJE; Stoker J; Bipat S
    Pediatr Radiol; 2018 Feb; 48(2):241-252. PubMed ID: 29151119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.